Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab)
- 1 November 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (5) , 1103-1104
- https://doi.org/10.1111/j.1365-2133.2004.06239.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Angiolymphoid Hyperplasia With Eosinophilia: A Classic Clinical Presentation With Histologic Features of AngiosarcomaDermatologic Surgery, 2002
- Angiolymphoid Hyperplasia With Eosinophilia Associated With Anomalous Dilatation of Occipital Artery: IL-5 and VEGF Expression of Lesional Mast CellsArchives of Dermatology, 2002
- Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeysJournal of Allergy and Clinical Immunology, 2001
- Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic responsePublished by Elsevier ,2001
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- Angiolymphoid hyperplasia with eosinophilia associated with arteriovenous malformation: a clinicopathological correlation with angiography and serial estimation of serum levels of renin, eosinophil cationic protein and interleukin 5British Journal of Dermatology, 1999
- Bcl-2 expression by eosinophils in a patient with hypereosinophiliaJournal of Allergy and Clinical Immunology, 1998
- Angiolymphoid hyperplasia with eosinophiliaJournal of the American Academy of Dermatology, 1985